Life ScienceCompany
Synpromics Ownership
Who owns Synpromics?
Synpromics is owned by Asklepios BioPharmaceutical. It was acquired on August 13, 2019.
Was Synpromics formerly PE-backed?
Yes. Synpromics was formerly owned by 1 private investor.
Synpromics Business Overview
Where is Synpromics headquartered?
Synpromics is headquartered in Edinburgh, United Kingdom.
What sector is Synpromics in?
Synpromics is a life science company.
When was Synpromics founded?
Synpromics was founded in 2010.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.